We are interested in the mechanisms of the biomedical and toxicological/ pathological effects of nanosystems for therapy and diagnosis (nanothernostics) at the biochemical, cellular and organismic level. We are engaged in i) studying the cytotoxic, pro-inflammatory, immunomodulatory and bio-compatibility of nanoparticles; ii) assessing and engineering their modulation by peptides (included insect and mold AMPs ), microbial and host-derived molecules (nanoparticle protein corona); iii) using this information to optimise the design and performance of multi-layered targeted nanoassemblies for drug delivery or PDT.